Home / Research Areas / Precision & Genomic Medicine

Same Diagnosis, Different Biology — Find the Treatment That Fits the Patient

Most treatment guidelines are built around how the average patient responds. But people differ — genetically, biologically, in how they process drugs — and those differences can be the gap between a treatment working and a treatment failing. This pathway trains you to find the patient subgroups hiding inside a single diagnosis.

What Researchers in This Area Do

Finding the Subgroup Inside the Diagnosis

Network and systems approaches help find subgroups of patients within a single disease who share an underlying molecular signature — even when they look clinically identical on the surface.

Cluster patients into subgroups using genetic, molecular, or clinical similarity

Study pharmacogenomics — how genetic variants affect how patients metabolize and respond to specific drugs

Evaluate candidate biomarkers for real clinical usefulness, not just statistical significance

Work with large biobank datasets linking genetics to real health outcomes over time

Why It Matters

Closing the Gap Between "Interesting" and "Useful"

Precision medicine is already changing clinical practice — genetic testing before certain prescriptions, molecular subtyping before choosing cancer treatment, risk scores combining dozens of genetic variants. The gap between "we found something statistically interesting" and "this changes what a doctor does" is where most precision medicine research effort actually goes — and it's exactly what this area trains students to evaluate.

Close up of medical worker holding tablet with brain hologram floating at laboratory with blurring background. Doctor checking at brain research for diagnosis patient symptom. Technology. Remedial.
Sample Research Project

What a Summer Project Looks Like

Precision & Genomic Medicine

Do Genetic Subtypes Predict Treatment Response? A Patient Stratification Study

Using a publicly available biobank or cohort dataset, a student identifies a disease with known clinical heterogeneity. They apply clustering and dimensionality-reduction methods to multi-omics or genetic data to identify distinct patient subgroups, then investigate whether those subgroups correspond to meaningfully different outcomes or treatment responses. The project includes a critical evaluation step: is this subgrouping statistically real, and would it actually hold up in a new group of patients? Mentored by a clinical genomics researcher or biostatistician, the student produces a written analysis and a visualization of the patient subgroups discovered.

Clustering & Dimensionality ReductionPharmacogenomicsBiomarker EvaluationBiobank-Scale Data

Precision & Genomic Medicine

Do Genetic Subtypes Predict Treatment Response? A Patient Stratification Study

Using a publicly available biobank or cohort dataset, a student identifies a disease with known clinical heterogeneity. They apply clustering and dimensionality-reduction methods to multi-omics or genetic data to identify distinct patient subgroups, then investigate whether those subgroups correspond to meaningfully different outcomes or treatment responses. The project includes a critical evaluation step: is this subgrouping statistically real, and would it actually hold up in a new group of patients? Mentored by a clinical genomics researcher or biostatistician, the student produces a written analysis and a visualization of the patient subgroups discovered.

Clustering & Dimensionality Reduction

Pharmacogenomics

Biomarker Evaluation

Biobank-Scale Data

Course by Track

How Each Level Gets There

Every track takes a shared Fall foundations course, then this area-specific Spring course, then a live mentored summer project.

High School

HS-S-PM

Undergraduate

UG-S-PM

Medical Student

MS-S-PM

Clinician

CL-S-PM